Anticorps Polyclonal de lapin anti-JNK

JNK Polyclonal Antibody for WB, IF/ICC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IF/ICC, ELISA

Conjugaison

Non conjugué

Publications(8)

N° de cat : 17337-1-AP

Synonymes

MAPK9, JNK2A, JNK2, JNK 55, EC:2.7.11.24



Applications testées

Résultats positifs en WBtissu cérébral de souris
Résultats positifs en IF/ICCcellules SH-SY5Y

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:200-1:1000
Immunofluorescence (IF)/ICCIF/ICC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

17337-1-AP cible JNK dans les applications de WB, IF/ICC, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Réactivité citéerat, Humain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène JNK Protéine recombinante Ag11372
Nom complet mitogen-activated protein kinase 9
Masse moléculaire calculée 424 aa, 48 kDa
Poids moléculaire observé 48 kDa
Numéro d’acquisition GenBankBC032539
Symbole du gène JNK
Identification du gène (NCBI) 5601
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

c-Jun N-terminal kinases (JNKs), first characterized as stress-activated members of the mitogen-activated protein kinase (MAPK) family, have shown their critical roles in the development of a number of cellular progress and diseases, including proliferation, embryonic development, apoptosis, diabetes, neurodegeneration and liver disease (PMID: 19900593). JNK1, JNK2, JNK3 also name as MAPK8, MAPK9, MAPK10, JNK1 and JNK2 are ubiquitously expressed, but JNK3 is expressed primarily in the brain (PMID: 27698029). This antibody can recognize JNK1, JNK2 and JNK3, we get bands around 44-55 kDa.

Protocole

Product Specific Protocols
WB protocol for JNK antibody 17337-1-APDownload protocol
IF protocol for JNK antibody 17337-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Biomed Pharmacother

Molecular mechanism through which Tripterygium hypoglaucum (Lévl.) Hutch alleviates psoriasis

Authors - Yumei Sun
mouseWB

Int Immunopharmacol

RG108 attenuates acute kidney injury by inhibiting P38 MAPK/FOS and JNK/JUN pathways

Authors - Fan-Xu Kong
mouseWB

Adv Sci (Weinh)

Ultra-Long-Term Anti-Inflammatory Polyphenol Capsule to Remodel the Microenvironment for Accelerating Osteoarthritis Healing by Single Dosage

Authors - Shaoyin Wei
humanWB

BMC Cancer

Aldo-keto reductase family 1 member C3 mediates radioresistance of esophageal cancer cells through suppressing MAPK and AKT signaling

Authors - Wei Xiong
mouseWB

Cardiovasc Diabetol

ANXA1-FPR2 axis mitigates the susceptibility to atrial fibrillation in obesity via rescuing AMPK activity in response to lipid overload

Authors - Peng Liu
ratWB

Int Immunopharmacol

Kaempferol attenuates experimental autoimmune neuritis through TNFR1/JNK/p38 signaling pathway inhibition

Authors - Li Wang
{{ptg:RelatedPrimaryAntibodies}}